Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Genus (LSE:GNS): Genetics Growth and Licensing Income Put Earnings Quality in Focus

Genus plc (LSE:GNS) is in focus on 13 October 2026 as investors assess the latest company-specific developments and the outlook for the FTSE 250. Genus is attracting attention as investors assess its genetics-led growth model, including breeding technology, genetic improvement and licensing income. Its …

Ankur Sharma | 13 October 2026

GSK plc (LSE:GSK): What could move this FTSE 100 stock next as investors reassess its growth outlook?

GSK plc (LSE:GSK) is in focus on 13 October 2026 because investors are weighing company-specific developments alongside the wider direction of UK equities. The central question is whether its operating performance can translate into durable earnings, cash flow and shareholder value. For a listed …

Ankur Sharma | 13 October 2026

Haleon (LSE:HLN) in Focus: What Could Move the FTSE 100 Stock Next?

Haleon (LSE:HLN) is a healthcare stock in the FTSE 100, with investor attention centred on consumer-health brand demand, pricing and category growth across oral health and wellness.

Ankur Sharma | 13 October 2026

CVS Group (LSE:CVSG): Australia Expansion and UK Veterinary Demand Drive the Next Growth Debate

CVS Group is in focus as investors digest its latest full-year performance and assess the next phase of growth across the UK and Australia. For the year ended 30 June 2026, revenue increased 5.9% to £712.8 million, like-for-like sales rose 2.1%, and adjusted EBITDA …

Ankur Sharma | 13 October 2026

AstraZeneca PLC (LSE:AZN): What could move this FTSE 100 stock next as investors reassess its growth outlook?

AstraZeneca PLC (LSE:AZN) is in focus on 13 October 2026 because investors are weighing company-specific developments alongside the wider direction of UK equities. The central question is whether its operating performance can translate into durable earnings, cash flow and shareholder value. For a listed …

Ankur Sharma | 13 October 2026

ConvaTec Group (LSE:CTEC) in Focus: What Could Move the FTSE 100 Stock Next?

ConvaTec Group (LSE:CTEC) is a healthcare stock in the FTSE 100, with investor attention centred on demand for advanced wound care and recurring medical products.

Ankur Sharma | 13 October 2026

Why NIOX Group (LSE:NIOX) Is Proposing a Tender Offer as a FTSE AIM All Share Index Constituent

NIOX develops and sells point-of-care devices that measure fractional exhaled nitric oxide, a marker of type 2 airway inflammation used in the diagnosis and management of asthma. Its products are used by clinicians in primary and specialist care, and the company also earns trial-related …

Divya Sood | 13 October 2026

How Ondine Biomedical (LSE:OBI) is turning Phase 3 success into a fundraise on the FTSE AIM All Share Index

Ondine is a Canadian life sciences group listed on AIM. It develops light-activated antimicrobial therapies. Its lead product, Steriwave, is a nasal photodisinfection treatment designed to reduce hospital infections, including surgical site infections. Steriwave is authorised in Canada, the UK and certain other markets. …

Divya Sood | 13 October 2026

What OptiBiotix Health (LSE:OPTI) orders mean for the microbiome group in the FTSE AIM All Share Index

OptiBiotix develops and commercialises products and ingredients aimed at improving health through the gut microbiome. Its main commercial products include SlimBiome, a weight management ingredient, and the SweetBiotix platform, which focuses on prebiotic fibres. It sells to partners in multiple regions, including Asia, Australia …

Divya Sood | 13 October 2026

Why Cambridge Nutritional Sciences (LSE:CNSL) remains a niche diagnostics play within the FTSE AIM All Share Index

The company develops and sells diagnostic tests linked to nutrition and wellbeing, with a particular focus on food intolerance testing. Its products are designed to help practitioners and consumers identify foods that may be associated with symptoms, so that diets can be adjusted. The …

Ankur Sharma | 13 October 2026
Support

Hi! How can we help you today?

Loading…